LAZ compared with BIO: revenue, margins and what each company keeps, and the suppliers and customers both name

LAZLazard, Inc.

Mkt capRevenueRevenue

BIOBio-Rad Laboratories, Inc.

Mkt capRevenueRevenue

Compare

LAZLazard, Inc.

BIOBio-Rad Laboratories, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LAZ 3

TBPHTheravance Biopharmacustomer

—Moody's Investors Serviceunlistedsupplier

—Dealogicunlistedsupplier

Shared 0

No shared counterparties.

Only BIO 2

BDSXBiodesixcustomer

IMDXInsight Molecular Diagnosticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

LAZLazard, Inc.

38.37▼−2.95%· post 38.37

Mkt cap$4.2BRevenue$836MQ3 FY26Revenue$3.2BFY25

BIOBio-Rad Laboratories, Inc.

372.18▼−3.18%· post 372.18

ClosedOct 30 '26

Mkt cap$10.0BRevenue$651MQ2 FY26Revenue$2.6BFY25

Compare

ClosedOct 30 '26

LAZLazard, Inc.

BIOBio-Rad Laboratories, Inc.

38.37▼−2.95%post 38.37

Price

372.18▼−3.18%post 372.18

$4.2B

Mkt cap

$10.0B

Q3 FY26$836M

Revenue

$651MQ2 FY26

FY25$3.2B

Revenue

$2.6BFY25

LAZ38.37▼−2.95%vsBIO372.18▼−3.18%ClosedOct 30 '26